Cyted Health is a biotechnology company developing non-endoscopic diagnostic methods that leverage cellular and molecular science to detect digestive diseases at an early stage. By applying biological insights, the company creates tools designed to identify disease markers without invasive procedures, expanding access to early diagnosis and advancing digestive healthcare worldwide.
Marcel Gehrung, co-founder and CEO, summarizes the company’s mission plainly. “We saw a clear gap where many patients delayed or avoided screening due to the invasive nature of existing tests. Our goal was to change that with a method that fits into routine care and encourages earlier intervention.”
Bridging the Divide Between Suspicion and Confirmation
Digestive diseases often show vague symptoms, which makes early detection critical. Yet endoscopy, the current diagnostic standard, remains inaccessible or intimidating for many patients. Cyted Health’s approach offers an alternative. It employs a non-invasive method to collect and analyze biological samples that reveal early warning signs, empowering primary care physicians to act promptly and with confidence.
This approach reshapes the dialogue around digestive health screening by prioritizing practicality and patient comfort. Marcel explains, “Effective screening isn’t just about detection; it’s about ensuring that diagnosis leads directly to timely and appropriate care. We work to smooth that transition.”
Rooted in Patient and Clinical Realities
Cyted Health’s progress depends on close collaboration with clinicians and patients alike. Its solutions are shaped by continuous feedback and a deep understanding of healthcare’s operational realities. Each phase—from development through deployment—prioritizes seamless integration into medical workflows without imposing extra burdens on staff or patients.
Reflecting on the early days, Marcel notes, “Listening to patients made it clear what matters most — comfort, speed, and confidence in the results. Technology alone is not enough. It must serve people.” This patient-first outlook directs Cyted’s efforts to educate providers and support patients throughout their diagnostic journey.
Setting a New Standard in Digestive Care
More than a diagnostic developer, Cyted Health serves as a catalyst for broader change. By delivering accessible, non-invasive diagnostics, the company is helping transform how digestive diseases are detected and managed worldwide. Marcel offers a measured perspective, “Our work isn’t about adopting the latest technology simply because it’s new. It’s about creating solutions that can be implemented everywhere, regardless of resources or location.”
This commitment marks a shift toward making early intervention a standard practice, not a rare exception. With this vision, Cyted Health is not just influencing medical protocols — it is improving countless lives through earlier, more effective care.
Marcel Gehrung | Co-Founder & CEO
Marcel Gehrung brings a pragmatic yet visionary approach to healthcare innovation. With a background that spans both life sciences and business, he understands the critical gap between cutting-edge research and practical patient care. Marcel’s leadership is grounded in a clear recognition of real-world challenges—particularly the barriers patients face with invasive diagnostic procedures. His focus remains steadfast on developing accessible solutions that integrate smoothly into everyday clinical practice. Under his guidance, Cyted Health continues to prioritize patient comfort and early detection, reflecting his commitment to improving outcomes through innovation that respects both science and the people it serves.
